What labeling information is required on compounded sterile preparations in Colorado?

The required labeling information on compounded sterile preparations in Colorado is crucial for multiple reasons, including patient safety and regulatory compliance. Compounded sterile preparations must include the medication name, strength, dosage form, beyond-use date, and any relevant information that ensures safe and effective administration of the medication.

The medication name ensures that anyone handling or administering the preparation can quickly identify the product. The strength is vital for dosing considerations, preventing potential underdosing or overdosing. The dosage form informs the route and method of administration, which can significantly impact the stability and efficacy of the preparation.

The beyond-use date is a critical component of labeling as it indicates the period during which the compounded preparation is expected to remain safe and effective. This helps in minimizing risks associated with the degradation of the compound over time. Including relevant information, such as storage conditions or specific handling instructions, can further safeguard against errors and enhance patient care.

This comprehensive labeling is aligned with both state and federal regulations to uphold the highest standards in pharmaceutical care and ensure that all sterile preparations are used safely. Thus, the selection that includes all these elements reflects the legal and ethical obligations of pharmacists in Colorado regarding compounded sterile preparations.